Comments
Shares of Unichem Laboratories Ltd, a mid-sized Indian drugmaker, today jumped as much as 3 per cent to Rs 315.75.
The drugmaker is exploring the sale of its domestic formulations business, and its proposal “is being studied’’ by private equity firms and strategic investors, a media report said, citing unnamed sources.
Potential suitors could include Teva Pharmaceuticals Ltd , Mylan Inc, Abbott Laboratories Ltd, Sanofi PA, and Pfizer Inc, the report said, citing sources.
Unichem’s Managing Director Prakash Mody denied the report on local television channel CNBC-TV18 on Monday, and said the company had no plans to sell a stake.
The company did not immediately respond to a request for comment by Reuters.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.